iCAD to Merge with CADx and Qualia Computing
|
By HospiMedica staff writers Posted on 15 Dec 2003 |
An agreement has been announced whereby iCAD, Inc. (Nashua, NH, USA; www.icad.med.com) will merge with privately held CADx (Beavercreek, OH, USA) and Qualia Computing, Inc. (also in Beavercreek). Currently, the companies are working on a joint and coordinated basis.
The combination of iCAD and CADx represents a merger of two growing computer-aided detection (CAD) companies with complementary strengths and minimal duplication of activities. iCAD and CADx have installed more than 300 CAD systems for the early detection of breast cancer. CADx anticipates profitable operations in the fourth quarter of 2003 and in 2004, while iCAD has projected profitable operations for 2004. To complete the merger, iCAD will issue 4.3 million shares of its common stock in exchange for all outstanding shares of Qualia Computing, Inc. and CADx System, Inc. In addition, iCAD will pay U.S.$1.55 million in cash and execute a 36-month promissory note in the amount of $4.5 million to purchase Qualia shares owned by two institutional investors. CADx will operate as an independent subsidiary of iCAD, Inc.
"The benefits of this merger for CADx and its customers include access to iCAD's new iQ technology, which allows all women's healthcare facilities, regardless of size, to offer CAD solutions to women at risk,” said Dr. Steven Rogers, president and CEO of CADx and Qualia Computing.
Related Links:
ICAD
CADx
Qualia Computing
The combination of iCAD and CADx represents a merger of two growing computer-aided detection (CAD) companies with complementary strengths and minimal duplication of activities. iCAD and CADx have installed more than 300 CAD systems for the early detection of breast cancer. CADx anticipates profitable operations in the fourth quarter of 2003 and in 2004, while iCAD has projected profitable operations for 2004. To complete the merger, iCAD will issue 4.3 million shares of its common stock in exchange for all outstanding shares of Qualia Computing, Inc. and CADx System, Inc. In addition, iCAD will pay U.S.$1.55 million in cash and execute a 36-month promissory note in the amount of $4.5 million to purchase Qualia shares owned by two institutional investors. CADx will operate as an independent subsidiary of iCAD, Inc.
"The benefits of this merger for CADx and its customers include access to iCAD's new iQ technology, which allows all women's healthcare facilities, regardless of size, to offer CAD solutions to women at risk,” said Dr. Steven Rogers, president and CEO of CADx and Qualia Computing.
Related Links:
ICAD
CADx
Qualia Computing
Latest Business News
- Teledyne to Acquire Varex Imaging in $1.1 Billion Deal
- MIMEDX to Add Sanara MedTech’s Regenerative Technologies Through $350 Million Deal
- AI Software Combines Nodule Detection and Diagnosis for Lung Cancer Screening
- AI Care Platform Adds Quantitative MRI Analysis for Multiple Sclerosis
- Danaher Completes Acquisition of Masimo to Expand Patient Monitoring Capabilities
- Endologix Adds FDA-Cleared Peripheral Thrombectomy System
- Artivion Adds FDA-Approved NEXUS System to Aortic Arch Portfolio
- Olympus Partnership Aims to Expand Access to Robot-Assisted Endoscopic Therapy
- Johnson & Johnson Launches AI-Driven Cardiac Mapping System
- Proximie Advances AI-Driven Intelligent Operating Rooms with NVIDIA Collaboration
- GE HealthCare, DeepHealth Expand AI Breast Imaging Collaboration
- Sinocare Presents AI-Driven Integrated Digital Health Solutions at CMEF
- GE HealthCare and Medtronic Expand Alliance with Intraoperative Imaging Integration
- New Partnership Advances Physical AI into Perioperative Workflows
- External Liver Assist System Receives FDA RMAT Designation
- New Partnership Expands Access to Predictive Tool for Patient Monitoring
Channels
Artificial Intelligence
view channel
AI Tool Predicts Post-Heart Attack Trajectories to Personalize Follow-Up
Acute myocardial infarction (heart attack) survivors often develop new comorbidities and complications that unfold over years. Predicting which patients will deteriorate and where problems will arise remains... Read more
AI Digital Twin Platform Supports Personalized Cancer Treatment
Oncology teams face persistent challenges in tailoring treatment plans as tumors evolve and responses vary across patients. Static snapshots from imaging or genomics offer limited guidance for complex... Read more
Study Reveals Persistent Race and Gender Bias in Medical AI Models
Hospitals are turning to artificial intelligence (AI) to draft clinical materials and support decision-making, yet algorithmic bias can entrench inequities in care. When generated content reflects racial... Read more
New Study Highlights Benefits and Risks of AI Explanations in Clinical Diagnosis
Explainable artificial intelligence is increasingly used in tools that help clinicians and patients assess skin disease, but its explanations can influence decisions and contribute to overreliance or error.... Read moreCritical Care
view channel
New Multimodal Framework Targets Debilitating Form of Heart Failure
Heart failure with preserved ejection fraction (HFpEF) occurs when the left ventricle becomes stiff and thickened despite maintaining a normal ejection fraction. The condition is increasingly common with... Read more
Personalized Neuromodulation System Receives FDA Clearance for PTSD Treatment
Post-traumatic stress disorder (PTSD) is a trauma-related mental health condition marked by persistent reexperiencing, hyperarousal, and avoidance that can impair daily functioning. Many patients, including... Read moreSurgical Techniques
view channel
Robot-Assisted Surgery Shows Advantages Over Laparoscopy in Gastric Cancer
Gastric cancer is most often treated with surgery, yet minimally invasive techniques can be technically challenging. Laparoscopic gastrectomy reduces recovery time compared with open surgery but relies... Read more
New Implant-Based System Gains FDA Approval for GERD Treatment
Gastroesophageal reflux disease is often treated surgically with techniques that encircle the esophagus, a strategy associated with dysphagia, inability to belch or vomit, and gas bloating.... Read morePatient Care
view channel
Multicenter Study Quantifies Delays in Care for Emergency Department Boarders
Emergency department (ED) boarding—the practice of keeping admitted patients in the ED while awaiting an inpatient bed—creates hazardous delays in definitive care. Prolonged transitions expose older and... Read more
Real-Time Radiation Monitor Supports Safer Fluoroscopy-Guided Procedures
Fluoroscopy-guided procedures expose clinicians to scatter radiation that accumulates over time, creating persistent occupational risks in cath labs and interventional suites. Traditional badges typically... Read moreMedical Imaging
view channel
AI Analyzes Spinal X-Rays to Standardize Scoliosis Assessment
Scoliosis, an abnormal sideways curvature of the spine that often arises in adolescence, is gauged on radiographs using angular measurements. These measurements guide diagnosis, follow-up, and treatment... Read more
Imaging Precision Tool Enables Method Comparison Without Ground-Truth Data
Quantitative measurements from medical images increasingly guide diagnosis and treatment, yet their reliability can be difficult to verify in routine care. In many cases, the true value of what is being... Read more
AI-Derived Brain Age from MRI Predicts Future Dementia Risk
Early identification of patients likely to progress to dementia remains difficult in memory clinics, where visual ratings of brain atrophy may miss subtle early changes. Dementia develops gradually and... Read more
Imaging Biomarkers Aim to Personalize Treatment for Post-Stroke Bladder Dysfunction
Post-stroke lower urinary tract dysfunction, including urinary incontinence, affects many stroke survivors and can persist long after the acute event. These symptoms undermine independence, burden caregivers,... Read moreHealth IT
view channel
Imaging Tool Quantifies Calcinosis Cutis Volume to Monitor Treatment
Calcinosis cutis involves calcium deposits in the skin or soft tissues that can develop anywhere in the body, causing pain, impaired mobility, and disability. Lesions along the spine or buttocks can make... Read more
Digital Symptom Monitoring Supports More Personalized Breast Cancer Care
Metastatic breast cancer, in which tumors spread to other organs, is incurable but increasingly managed with modern systemic therapies. As more treatments shift from hospital infusions to oral or at-home... Read morePoint of Care
view channel







